• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和腹水 C 反应蛋白在良恶性腹水鉴别诊断中的意义。

Significance of serum and ascitic fluid C-reactive protein in differential diagnosis of benign and malignant ascites.

机构信息

Department of Gastroenterology, Dıskapı Yıldırım Beyazıt Educational and Research Hospital, 06080, Altındag, Ankara, Turkey.

出版信息

Dig Dis Sci. 2014 Oct;59(10):2588-93. doi: 10.1007/s10620-014-3205-4. Epub 2014 May 18.

DOI:10.1007/s10620-014-3205-4
PMID:24838501
Abstract

BACKGROUND

The values of C-reactive protein (CRP) can prove useful in determining disease progress. Because of synthesis by the liver, production of CRP in response to inflammation may be attenuated in patients with liver dysfunction. This may result in differences interpreting CRP levels in patient with portal and non-portal hypertension ascites.

AIM

The aim of the present study is to assess discriminant value of serum and ascitic fluid CRP, which is easily accessible and inexpensive laboratory marker of inflammation, concentrations for diagnosis of underlying cause of ascites.

METHODS

This prospective study was conducted at Dıskapı Yıldırım Beyazıt Educational and Research Hospital Department of Gastroenterology. Patients with ascites were further divided into two subgroups based on underlying cause of ascites: Group 1, patient with ascites due to portal hypertensive etiology (high-gradient ascites); Group 2, patient with ascites due to non-portal hypertensive etiology (low-gradient ascites).

RESULTS

A total of 91 patients fulfilling the criteria for a diagnosis of ascites were enrolled in the study. Of these patients, 50 had proven (Group 1) ascites due to portal hypertensive etiology (high-gradient ascites) and 41 had clinical (Group 2) ascites due to non-portal hypertensive etiology (low-gradient ascites). Mean baseline serum and ascites levels of CRP were significantly higher in Group 2 compared to those in Group 1 (p = 0.021, p = <0.0001, respectively).

CONCLUSIONS

Increased levels of serum and ascitic fluid CRP were associated with malignant ascites.

摘要

背景

C 反应蛋白(CRP)的值可用于确定疾病的进展。由于肝脏合成,CRP 对炎症的产生可能会在肝功能障碍的患者中减弱。这可能导致对门脉高压和非门脉高压性腹水患者的 CRP 水平的解释存在差异。

目的

本研究旨在评估血清和腹水 CRP 这一易于获取且价格低廉的炎症实验室标志物,对于诊断腹水潜在病因的鉴别价值。

方法

这项前瞻性研究在迪亚斯帕伊耶尔德兹姆贝伊扎蒂尔教育和研究医院胃肠病学部进行。腹水患者根据腹水的潜在病因进一步分为两组:第 1 组,由门脉高压病因引起的腹水患者(高梯度腹水);第 2 组,由非门脉高压病因引起的腹水患者(低梯度腹水)。

结果

共有 91 名符合腹水诊断标准的患者入组本研究。其中,50 名患者被证实(第 1 组)存在由门脉高压引起的腹水(高梯度腹水),41 名患者存在临床(第 2 组)由非门脉高压引起的腹水(低梯度腹水)。第 2 组的血清和腹水 CRP 基线水平明显高于第 1 组(p=0.021,p<0.0001)。

结论

血清和腹水 CRP 水平升高与恶性腹水有关。

相似文献

1
Significance of serum and ascitic fluid C-reactive protein in differential diagnosis of benign and malignant ascites.血清和腹水 C 反应蛋白在良恶性腹水鉴别诊断中的意义。
Dig Dis Sci. 2014 Oct;59(10):2588-93. doi: 10.1007/s10620-014-3205-4. Epub 2014 May 18.
2
C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.C反应蛋白和胰岛素样生长因子-1在腹水鉴别诊断中的作用
J Gastroenterol Hepatol. 2016 Nov;31(11):1868-1873. doi: 10.1111/jgh.13386.
3
The role of ascitic fluid viscosity in differentiating the nature of ascites and in the prediction of renal impairment and duration of ICU stay.腹水黏度在鉴别腹水性质、预测肾功能损害及重症监护病房(ICU)住院时间方面的作用。
Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1021-7. doi: 10.1097/MEG.0000000000000669.
4
Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites.腹水总蛋白:非门静脉高压性腹水的有用标志物。
J Gastroenterol Hepatol. 2020 Feb;35(2):271-277. doi: 10.1111/jgh.14768. Epub 2019 Jul 15.
5
The role of ascitic fluid viscosity in the differential diagnosis of ascites.腹水液粘度在腹水鉴别诊断中的作用。
Can J Gastroenterol. 2010 Apr;24(4):255-9. doi: 10.1155/2010/896786.
6
The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.血清腹水白蛋白梯度在腹水诊断中用于确定门静脉高压的价值。
Hepatogastroenterology. 2001 Jan-Feb;48(37):166-8.
7
Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.卡塔尔的腹水情况:腹水分析的病因及诊断价值
Singapore Med J. 2007 May;48(5):434-9.
8
[Diagnostic of ascites due to portal hypertension: accuracy of the serum-ascites albumin gradient and protein analises in ascitic fluid].[门静脉高压所致腹水的诊断:血清-腹水白蛋白梯度及腹水蛋白质分析的准确性]
Rev Gastroenterol Peru. 2014 Jan-Mar;34(1):23-8.
9
Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites.血清白蛋白对腹水白蛋白梯度和腹水总蛋白在儿科腹水的临床应用。
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101549. doi: 10.1016/j.clinre.2020.09.010. Epub 2020 Oct 23.
10
Role of serum-ascites albumin gradient in differential diagnosis of ascites.血清腹水白蛋白梯度在腹水鉴别诊断中的作用
J Ayub Med Coll Abbottabad. 2012 Jul-Dec;24(3-4):97-9.

引用本文的文献

1
Possible use of 2D shear wave liver elastography in new-onset ascites evaluation.二维剪切波肝脏弹性成像在新发腹水评估中的可能应用。
BMC Gastroenterol. 2024 Feb 8;24(1):68. doi: 10.1186/s12876-024-03159-1.
2
Development and validation a simple model for identify malignant ascites.开发并验证一种简单的模型用于识别恶性腹水。
Int J Med Sci. 2021 Mar 3;18(9):1966-1974. doi: 10.7150/ijms.53743. eCollection 2021.
3
Comparative Assessment of Two Strategies for Interpreting Tumor Markers in Ascitic Effusions.比较两种方法在解读腹腔积液中肿瘤标志物的效果。

本文引用的文献

1
Serum-ascites albumin gradient in differential diagnosis of ascites.血清腹水白蛋白梯度在腹水鉴别诊断中的应用
Mymensingh Med J. 2013 Oct;22(4):748-54.
2
Persistent ascites after liver transplantation: etiology, treatment and impact on survival.肝移植术后持续性腹水:病因、治疗及对生存的影响。
Ann Transplant. 2013 Jul 24;18:378-83. doi: 10.12659/AOT.883982.
3
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.2012年美国肝病研究协会肝硬化所致成人腹水患者管理实践指南修订版介绍。
In Vivo. 2020 Mar-Apr;34(2):715-722. doi: 10.21873/invivo.11829.
4
Current approaches to the management of patients with cirrhotic ascites.当前肝硬化腹水患者管理方法。
World J Gastroenterol. 2019 Jul 28;25(28):3738-3752. doi: 10.3748/wjg.v25.i28.3738.
5
A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.C反应蛋白与血管内皮生长因子联合用于腹水鉴别诊断的新组合
J Gastrointest Cancer. 2017 Mar;48(1):50-57. doi: 10.1007/s12029-016-9873-x.
Hepatology. 2013 Apr;57(4):1651-3. doi: 10.1002/hep.26359.
4
The Light criteria: the beginning and why they are useful 40 years later.光标准:40 年后的开始和为什么它们有用。
Clin Chest Med. 2013 Mar;34(1):21-6. doi: 10.1016/j.ccm.2012.11.006. Epub 2013 Jan 17.
5
Hypoalbuminemia.低蛋白血症。
Intern Emerg Med. 2012 Oct;7 Suppl 3:S193-9. doi: 10.1007/s11739-012-0802-0.
6
A novel approach: transumbilical endoscopic exploration and biopsy for patients with unknown ascites.一种新方法:经脐内镜探查及活检用于不明原因腹水患者。
J Laparoendosc Adv Surg Tech A. 2012 Sep;22(7):691-4. doi: 10.1089/lap.2012.0097. Epub 2012 Jul 24.
7
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南
J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.
8
C-reactive protein and malignancy: clinico-pathological association and therapeutic implication.C反应蛋白与恶性肿瘤:临床病理关联及治疗意义
Chang Gung Med J. 2009 Sep-Oct;32(5):471-82.
9
The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.评估肝硬化患者低血清白蛋白梯度腹水的效用。
Am J Gastroenterol. 2009 Jun;104(6):1401-5. doi: 10.1038/ajg.2009.117. Epub 2009 Apr 21.
10
Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis.腹水:病因、死亡率及自发性细菌性腹膜炎的患病率
Scand J Gastroenterol. 2009;44(8):970-4. doi: 10.1080/00365520902964739.